ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 001,80
-0,48%
Dow Jones
38 798,99
-0,22%
DAX
18 557,27
-0,48%
Brent Oil
79,345
-0,67%
Bitcoin
69 110,26
-2,34%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Idera Pharmaceuticals Inc (IDRA)

  7. Idera Pharmaceuticals Inc (IDRA) Actualités

IDRA

Idera Pharmaceuticals (IDRA)

Idera Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:IDRA
DateHeureSourceTitreSymboleSociété
29/06/202322h31Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IDRAIdera Pharmaceuticals Inc
24/06/202301h20Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:IDRAIdera Pharmaceuticals Inc
17/05/202315h50Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:IDRAIdera Pharmaceuticals Inc
15/05/202323h08Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:IDRAIdera Pharmaceuticals Inc
13/04/202322h32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
10/04/202322h41Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:IDRAIdera Pharmaceuticals Inc
03/04/202312h00Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
30/03/202322h52Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
28/03/202317h29Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:IDRAIdera Pharmaceuticals Inc
14/02/202323h00Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IDRAIdera Pharmaceuticals Inc
01/02/202322h44Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:IDRAIdera Pharmaceuticals Inc
18/01/202322h46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
17/01/202314h00GlobeNewswire Inc.Idera Pharmaceuticals Announces Name Change to Aceragen, Inc. and Provides Near-Term Strategic OutlookNASDAQ:IDRAIdera Pharmaceuticals Inc
09/12/202222h50Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:IDRAIdera Pharmaceuticals Inc
14/11/202222h05GlobeNewswire Inc.Idera Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:IDRAIdera Pharmaceuticals Inc
28/09/202223h01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:IDRAIdera Pharmaceuticals Inc
28/09/202222h09GlobeNewswire Inc.Idera Pharmaceuticals Acquires AceragenNASDAQ:IDRAIdera Pharmaceuticals Inc
09/08/202222h15GlobeNewswire Inc.Idera Pharmaceuticals Reports Second Quarter 2022 Financial ResultsNASDAQ:IDRAIdera Pharmaceuticals Inc
17/05/202214h04GlobeNewswire Inc.Idera Pharmaceuticals Shares Positive Results from Investigator-Sponsored Trial in Melanoma Patients at Amsterdam UMCNASDAQ:IDRAIdera Pharmaceuticals Inc
05/05/202222h15GlobeNewswire Inc.Idera Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:IDRAIdera Pharmaceuticals Inc
31/03/202222h26Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:IDRAIdera Pharmaceuticals Inc
31/03/202222h15GlobeNewswire Inc.Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate UpdateNASDAQ:IDRAIdera Pharmaceuticals Inc
14/12/202122h32GlobeNewswire Inc.Idera Pharmaceuticals Announces Tilsotolimod UpdatesNASDAQ:IDRAIdera Pharmaceuticals Inc
08/11/202122h14GlobeNewswire Inc.Idera Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate UpdateNASDAQ:IDRAIdera Pharmaceuticals Inc
09/08/202122h15GlobeNewswire Inc.Idera Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate UpdateNASDAQ:IDRAIdera Pharmaceuticals Inc
26/05/202112h05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:IDRAIdera Pharmaceuticals Inc
19/05/202112h02Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:IDRAIdera Pharmaceuticals Inc
18/05/202122h15GlobeNewswire Inc.Idera Pharmaceuticals Announces Corporate UpdatesNASDAQ:IDRAIdera Pharmaceuticals Inc
29/04/202122h10GlobeNewswire Inc.Idera Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate UpdateNASDAQ:IDRAIdera Pharmaceuticals Inc
28/04/202122h55Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:IDRAIdera Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:IDRA

Dernières Valeurs Consultées

LSE
80BR
Anz Bank 7.02%
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés